Jennifer A. Russo, MD Dr. Russo is a Clinical Fellow in Family Planning, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pa.
Mitchell D. Creinin, MD Dr. Creinin is the Director of Gynecologic Specialties and Director of Family Planning, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pa
Dr. Russo reports no financial relationships relevant to this article. Dr Creinin is a senior clinical advisor for Medicines360.
an examination table adjustable for height and position
an assistant to reassure and comfort the patient and to assist you.
We’re out from under a dark cloud
It’s been a long road for US clinicians, coming back from the damage done by the Dalkon Shield to their interest in inserting IUDs in nulliparous and adolescent women. But we are gradually seeing a change in both physicians’ and patients’ opinions about using intrauterine devices for these populations.
Demand is growing in the United States for long-acting reversible contraception; we need to challenge our reservations and provide the care that our patients are requesting. The opinions and advice of our supporting professional organizations, based on the recent literature, point to the appropriateness of embracing IUDs for nulliparous and adolescent women.
